SPHK2 and central nervous system cancer: This induced growth arrest and apoptosis, specifically in IDH-mutant gliomas highlighting a metabolic vulnerability characterized by elevated ceramides and decreased SPHK2 expression in IDH-mutant compared to IDH-wildtype gliomas.